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Gaizka Parra-Garcia5, Miguel Ángel Rodríguez-Calero6, Enrique Castro-Sánchez7 and on behalf of the Research
Group PREBACP
Abstract
Background: Peripheral venous catheters are the most commonly used invasive devices in hospitals worldwide.
Patients can experience multiple adverse events during the insertion, maintenance, and management of these
devices. Health professionals aim to resolve the challenges of care variability in the use of peripheral venous catheter
through adherence to clinical practice guidelines. The aim of this cluster-randomized controlled trial is to determine
the efficacy of a multimodal intervention on incidence of adverse events associated with the use of peripheral venous
catheters in adult hospital patients. Additional aims are to analyze the fidelity of nurses and the relationship between
contextual factors on the use of best available and the outcomes of the intervention.
Methods: Five public hospitals in the Spanish National Health System, with diverse profiles, including one university
hospital and four second-level hospitals, will be included. In total, 20 hospitalization wards will be randomized for this
study by ward to one of two groups. Those in the first group receive an intervention that lasts 12 months implementing
evidence-based practice in healthcare related to peripheral catheters through a multimodal strategy, which will contain
updated and poster protocols insertion, maintenance and removal of peripheral venous catheters, technologies applied
to e-learning, feedback on the results, user and family information related to peripheral catheter, and facilitation of the
best evidence by face-to-face training session. Primary outcome measures: Incidence of adverse events associated with
the use of peripheral venous catheters is measured by assessing hospital records. Secondary outcome measures: Nurses’
adherence to clinical practice guidelines, clinical outcomes, and the cost of implementing the multimodal intervention.
Discussion: Clinical implementation is a complex, multifaceted phenomenon which requires a deep understanding of
decision-making, knowledge mobilization, and sense making in routine clinical practice. Likewise, the inclusion of
strategies that promote fidelity to recommendations through multicomponent and multimodal intervention must be
encouraged. The use of a transfer model could counterbalance one of the greatest challenges for organizations, the
evaluation of the impact of the implementation of evidence in the professional context through quality indicators
associated with prevention and control of infections.
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Background
Peripheral venous catheters (PVC) are the most com-
monly used invasive devices in hospitals worldwide [1].
Patients can experience multiple adverse events such as
phlebitis, extravasation, or infections during the insertion,
maintenance, and management of these devices [2].
Among these adverse events, catheter-related bloodstream
infections (CRBSI) are catastrophic [3] yet potentially pre-
ventable episodes [4]. The incidence of PVC-associated
bloodstream infections (PVC-BSI) is between 0.1 and
0.5 per 1000 catheter days [5]. CRBSIs can prolong
length of hospital stay [2, 6] and carry an attributable
mortality rate of up to 25% [7, 8]. The approximate
average cost per episode of CRBSI is $45,000 and thus
resulting in $2.3 billion of unnecessary expenditure per
year in the USA [3].
The genesis of evidence-based clinical practice (EBCP)
is the integration of best available scientific knowledge in
combination with clinical experience and user preferences
on health and care issues [9–11]. Clinical practice guide-
lines (CPGs) are based on empirical evidence, developed
critically with explicit methods by experts, free of conflicts
of interest and with specific and unambiguous recommen-
dations [12]. These guidelines are developed to assist the
decision-making of health professionals and patients
about appropriate health care interventions in specific
clinical circumstances. However, CPGs are not exempt
from challenges [13]. The number of guidelines has grown
significantly and thus the volume of evidence proven to be
unmanageable and of variable quality [14]. Additionally,
there is frequent tardiness in the implementation of the
recommendations within the CPGs, probably fueled by
perceptions of clinical judgment as the main element in
clinical decision-making [15]. These facts can ultimately
weaken the credibility of CPGs and therefore increase the
difficulty of their implementation [16].
In the last decade, healthcare systems have also focused
on reducing the variability of healthcare practice [17].
International research agencies have conducted strategies
to effectively implement knowledge to resolve the chal-
lenges presented by clinical practice variability and offer
optimal, quality care to patients and citizens [18].
However, the introduction of innovations into daily clin-
ical practice remains arduous. Despite efforts to reduce the
research-practice gap, some studies suggest that 30–40% of
patients are still not offered care based on best available evi-
dence [19, 20]. Such gap is therefore a major threat to
patient safety and healthcare efficiency [21]. The use of
implementation models aims to enable the integration
of key elements which are in permanent and dynamic
interaction, such as research result innovations, the
individuals and teams that have to enact the change
and local and organizational context, which will be sup-
ported through the process of facilitation to warrant ef-
fective knowledge mobilization (EKM) [22–27]. Therefore,
the incorporation of a knowledge mobilization model
could be a feasible approach to reduce such research-
practice gap that it embed a deep understanding of de-
cision-making and key elements to promote adherence
of evidence-based practice [28].
This protocol describes a theoretical model to evaluate
the effectiveness of a multimodal intervention focused
on implementing evidence into clinical practice. Draw-
ing from the core elements of evidence, context, and fa-
cilitation present on The Promoting Action on Research
Implementation in Health Services (PARIHS) frame-
work, we will determine the efficacy of our planned
intervention on the incidence of adverse events associ-
ated with the use of PVC in adult patients in hospital.
This research will also unpack the relationship between
factors influencing local context and individual percep-
tions about the use of evidence-based practice.
Methods/design
Aims
1. To determine the efficacy of a multimodal
intervention to reduce the incidence of adverse
events (CRBSI, extravasation, obstruction, and
phlebitis) associated with the use of PVC in adult
patients in hospital.
2. To analyze the fidelity of nurses to the
recommendations within the CPG for insertion and
management of PVCs.
3. To associate post-intervention adverse event rates
with contextual and individual factors on the use of
best available knowledge in clinical practice decisions.
Primary hypothesis
The implementation of a multimodal intervention will de-
crease the incidence of adverse events (CRBSI, extravasa-
tion, obstruction and phlebitis) associated with the use of
PVCs in adult patients in hospital.
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Secondary hypotheses
1. Nursing practice outcomes: An optimal fidelity of
nurses to the recommendations within the CPG for
insertion and management of peripheral venous
catheter in hospital wards receiving the intervention
will translate into reduced care variability, increased
documentation about PVC use in nursing records
and greater requests of catheter tip culture from
PVCs removed from patients experiencing adverse
events.
2. Clinical outcomes: The fidelity of nurses to the
recommendations within the CPG for insertion and
management of peripheral venous catheter in
hospital wards receiving the intervention will
reduce unnecessary PVCs and decrease hospital
length of stay (HLOS).
3. Health economic outcomes: The implementation
and development costs of the intervention will be
offset by savings from decreased incidence of
CRBSIs and HLOS.
4. EBCP environment: The contextual and individual
factors on the utilization of knowledge in clinical
practice decisions and impact on hospital ward
processes and practice measured by Nursing Work
Index (NWI) [29] and Evidence-Based Practice
Questionnaire (EBPQ) [30].
Design
This knowledge mobilization study uses a pragmatic
cluster-randomized controlled trial (C-RCT) design, with
embedded process evaluation. Such design will allow the
measurement of clinical efficacy and costs of a multi-
modal intervention to improve PVC-related adverse
events as such as PVC-BSI and phlebitis. We will com-
pare outcomes and costs from implementation of CPGs.
The embedded process evaluation will elicit the variable
contexts of implementation, the barriers and enablers
encountered, the response by stakeholders, and the re-
sources required for implementation. The multicenter
nature of the study, with the inclusion of hospitals with
different organizational characteristics and located in
different geographic areas, will enhance the diversity of
the sample and thus its external validity. Reporting of
this trial will adhere to the CONSORT statement and its
extension to C-RCTs [31].
Setting
The study will be conducted in five public hospitals with
diverse characteristics within the Spanish National
Health System, including one reference hospital and four
acute care hospitals. Twenty wards will be selected and
randomly allocated to either the intervention or control
groups. The intervention will be delivered at ward level,
and therefore, the ward will be considered the unit of
analysis. Emergency, critical care, pediatric, maternity,
peri-operative, operative rooms, and psychiatric areas
will be excluded from the analysis, due to the fact that
peripheral catheters are routinely maintained inserted
for less than 24 h. Bias-compensating measures will be
incorporated to homogenize nursing practice through
face-to-face training in excluded wards.
Sample/participants
All healthcare staff working on the study wards and deliv-
ering direct care to adult inpatients will be involved in the
study. To ensure homogeneity between units, each ward
enrolled in the study must have a stable permanent staff,
reducing the possibility of contamination by personnel
movement.
Primary outcome measures: effect evaluation
The primary outcome will be the incidence of adverse
events associated with the use of PVCs in adult inpa-
tients. This incidence will be determined from evalu-
ation of hospital records at 3, 6, 9, and 12 months.
Secondary outcome measures: process evaluation
1. Nurses’ adherence to CPGs will be measured at 3, 6,
9, and 12 months with the following subcategories:
1.1 Multimodal intervention content will be delivered
as planned (yes/no), and dosage will be delivered as
often and long as planned (yes/no); face-to-face
training session will be assessed by measuring the
number of nurses who completed the Masterclass
at the intervention phase. Feedback will be
evaluated by checking the distribution of clinical
audit results within intervention wards. Patient
information will be assessed by monitoring the
presence of informative leaflets on the ward
(yes/no) and asking if the patient is aware of use
of PVC and prevention recommendations for
personal care. Facilitation will be measured by
number of internal facilitators who completed the
intervention.
1.2 Clinical audits on use of PVC. Device utilization
ratios will be measured by percentage of PVCs per
hospital wards and number of PVC per patient.
Documentation of PVC in nursing records will be
assessed by percentage of fully completed records.
PVC maintenance will be monitored by random,
monthly clinical audits, which will document PVC
size (16/18/20/22/24 gauge), site (dorsum of hand/
forearm/antecubital region/upper arm), dressing
integrity (clean/dry/intact), securement and time in
situ (less 48 h/ between 48 and 96 h/more 96 h).
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Catheter tip will be measured by number of
catheter tip extraction following removal of PVCs.
1.3 Routine practice. Clinical effectiveness
questionnaire for the prevention of PVC
complications will be completed pre and post
intervention. The questionnaire is made up of 35
questions in four sections, relating to general
asepsis and skin antisepsis; PVC insertion,
maintenance, and removal; PVC documentation;
and patient and professional education.
2. Clinical outcomes will be assessed using rates of
unnecessary PVCs, rates of CRBSI, extravasation,
obstruction and phlebitis, defined as per standard
guidelines, and mean HLOS associated to PVC-BSIs
at 3, 6, 9, and 12 months.
3. The direct costs of implementing the multimodal
intervention will be assessed using HLOS for
patients and decrease rates of adverse events at
12 months (post intervention).
4. EBCP environment:
4.1 EBCP context: The contextual factors on the
utilization of knowledge in clinical practice
decisions and impact on hospital ward processes
and practice will be assessed using the NWI tool
pre-intervention. The variables are summarized into
five main groups: nurses’ participation in hospital
affairs; quality of nursing care; nurse management’s
capacity, leadership, and support for nursing staff;
size of the nursing workforce and adaptation of
available human resources, and professional relation
between doctors and nurses.
4.2 EBCP individual: The opinions, attitudes, abilities
and motivations of nurses and their links with the
development of a culture of clinical practice based
on the transfer of new knowledge to the healthcare
given to patients will be assessed using EBPQ pre-
intervention. The questionnaire is made up of 24
questions relating to professionals’ knowledge, use
and attitudes towards EBCP.
Sample size
Calculations are based on a previous observational pilot
conducted in Manacor Hospital, which reported a global
rate of 44.1% PVC-associated adverse events (16% phle-
bitis, 6.8% obstruction, 18.1% extravasation, and 3.2%
CRBSIs rates of which 3.1% were CRBSIs type 1, 0.14%
CRBSIs type 2, and none CRBSIs type 3). Similar studies
have a potential for improvement between 7 and 19% in
adverse event rates, such as phlebitis, infiltration, and
obstruction, yet there is no statistical significance or
potential for improvement in CRBSI rates [32, 33]. The
initial assumption is for the intervention to decrease the
rate of adverse events associated with PVC in the inter-
vention group at 6 months post-intervention by 15%.
For such target result, the sample size required would be
1920 nursing records, accepting an alpha risk of 0.05, a
beta risk of 0.2 in a two-sided test, and 10% missing
data. For the calculation of sample size, the smallest
detectable difference with adequate power and statistical
significance has been considered. The sample size has
been corrected to account for within-intra cluster correl-
ation coefficient of 0.01 to allow for a design effect of
1.99. The final sample size will therefore be of 3821
nursing records, assuming an average cluster size of 200
nursing records.
Control group
The control ward will not receive the multimodal inter-
vention and will continue with routine practice.
Intervention group
The intervention will last 12 months and will be based on
a theoretical model on effective knowledge mobilization,
integrating a multimodal strategy related to peripheral
catheters clinical practice improvement which includes
the following (Fig. 1): (1) implementation of recommenda-
tions trough up-to-date protocols and posters related to
hand hygiene and aseptic measures, insertion, mainten-
ance and removal of PVC [34]; (2) use of e-learning
technologies [35–37]; (3) feedback on the results and
messages addressed to healthcare professionals to facilitate
adherence to recommendations [38]; (4) face-to-face
training sessions [39]. Masterclass related to PVC inser-
tion, maintenance, and removal will consist of information
shared about recommendation of CPGs adapted according
to the needs detected by means of the questionnaire on
the effectiveness of the healthcare practice; (5) leaflets
with information for patients and family/careers about
peripheral catheters, in appropriate language [40]; and (6)
support by internal facilitators, which will be key members
of staff in the organizations, to adopt best evidence based
on the PARIHS theoretical model [26, 41, 42].
This facilitation will be carried out by nurses using the
Facilitating Implementation of Research Evidence (FIRE)
approach, and who will flexibly tailor implementation
strategies to the local ward context, and to resolve bar-
riers and enablers identified. There will be two types of
FIRE agents: hospital leaders (hFIRE) and hospital ward
nurses (nFIRE). These agents will be allocated to the
wards of each hospital. To mitigate the potential risk of
facilitators leaving their posts during the study period
we will deploy a co-facilitation model with three support
nurses on each intervention ward. nFIRE nurses will be
appointed to support and train other nurses on the GPC
recommendations, carrying out the face-to-face training
in their units, working in small groups to review process
indicators and routines practices. Both nFIRE and hFIRE
will lead an education program based on the theory of
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planned behavior [43–45] which includes behavioral tech-
niques to facilitate the application of evidence-based
practice. At the hospital level, the hFIREs will audit
PVC-related practices, identifying barriers and providing
support and guidance to resolve such hurdles. The facilita-
tion strategy will be led by expert external facilitators, PRE-
BACP group research, working with both types of FIRE.
Data collection
To mitigate control bias, each nurse manager will be pro-
vided with information to standardize catheter removal,
catheter tip culture, and hemoculture extraction. Tips
from all PVC removed from patients experiencing adverse
events will be cultured using a semiquantitative method.
Clinical, microbiological, and ward information will be
collected from each patient on PVC removal.
Project investigators will collect primary and second-
ary outcome data using a wide range of methods, includ-
ing questionnaires NWI and EBPQ to nurses, clinical
audits monthly, and clinical outcome by requesting sta-
tistics report the participating wards at each hospital
with the variables. Where these data are not available,
clinical outcome data will be adapted from our research
to collect the primary and secondary outcome data.
Tools will be used for communication between facilita-
tors, auditors, and researchers to collect at the time of
activity and throughout the duration of the intervention.
The mean hospital length of stay for relevant wards will
be collected as reported by the hospital electronic patient
management systems. This data collection system was
piloted in five of the above hospital units in December
2017. Adverse events will be defined as per international
guidelines for the prevention of BSIs (Healthcare Infection
Control Practices Advisory Committee, USA, UK, Spain)
[46–48]. Three study phases will be planned for the
PREBACP study: baseline (2 months), intervention and
evaluation (12 months) (Fig. 2).
Definitions
(a) CRSBI: The following case definitions will be used
to determine a diagnosis of CRBSI (see Fig. 1):
▪ CRBSI type 1: Local PVC-related infection (no
positive blood culture): Positive quantitative culture
(103 CFU/ml) or semi-quantitative culture with more
than 15 CFU from the tip of PVC and local signs of
infection at the insertion site or in catheter lumen.
▪ CRBSI type 2: General PVC-related infection
(no positive blood culture positive): positive
quantitative culture (103 CFU/ml) or semi-quantitative
culture with more than 15 CFU from the tip of PVC
and that clinical signs improve within 48 h of catheter
removal.
Fig. 1 Theoretical model on effective knowledge mobilization
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▪ CRBSI type 3: PVC-BSI associated with
microbiologically confirmed with blood culture
occurring 48 h before or after catheter removal and
positive quantitative culture (103 CFU/ml) or a
semi-quantitative culture with more than 15 CFU
from the tip of PVC for the same microorganism.
(b) Phlebitis: An inflammation of the wall of a vein.
If a blood clot in the vein causes the
inflammation, then the condition is termed
thrombophlebitis. This problem is characterized
by persistent pain referred to PVC (2 h since the
last administration), erythema, swelling, and
palpable thrombosis of the cannulated vein.
(c) Extravasation: Inadvertent leakage of a vesicant
solution into surrounding tissue.
(d) Obstruction: Following occlusion of the PVC,
which can be partial (i.e., blood cannot be aspirated,
but PVC can be flushed) or complete, whereby
neither aspiration nor infusion are possible.
Data analysis
Effect evaluation and process evaluation
Quantitative methods will be used to analyze nursing
practices, health service utilization, and economic out-
comes. Main and secondary outcome analyses will be
based on all randomized wards and selected participants.
To account for within-patient correlation, due to multiple
measurements from the same patient during assessment
days, we will implement generalized estimating equation
models with binary outcome and logic link for all rate out-
come comparisons. The statistical analysis will consist of
an exploration of the descriptive data of the sample,
bivariate analysis with parametric and non-parametric
tests, depending on the nature of the distributions (correl-
ation, ANOVA, chi-square) and multivariate (multiple
regression with independence analysis using Durbin-Wat-
son statistics). The Cochran-Mantel-Haenszel test will be
used to compare proportions. A series of exploratory ana-
lyses will be conducted on sub-groups and the impact of
covariates on estimated of the effects of the intervention.
A nonparametric median test will be used for HLOS com-
parison. In supportive analysis, HLOS will be considered
as time to event data. Survival rates will be calculated and
illustrated by the Kaplan-Meier method and further ana-
lyzed by the long rank test for univariate analysis. Vari-
ables that reveal prognostic or effect modifying potential
on the outcome as suggested by univariate analysis will
subsequently be evaluated by the proportional Cox regres-
sion for multivariate analysis. Hazard ratios with corre-
sponding 95% confidence intervals will be reported. A p
value of < 0.05 will be considered statistically significant. A
regression model will be constructed to further explore
the results obtained in the bivariate analysis, seeking to
establish an explanatory model on the variables in-
volved in improving the use of recommendations.
Data will be analyzed using the program SPSS IBM
Statistics version 21.
BCP environment
Firstly, an exploratory analysis will be performed of char-
acteristics that define the behavior of each of the variables
Fig. 2 Timeline of PREBACP study
Blanco-Mavillard et al. Implementation Science  (2018) 13:100 Page 6 of 9
used, by means of classical descriptive techniques and the
exploratory data analysis procedure. Secondly, relations
will be analyzed between the professionals’ answers to the
two questionnaires (EBPQ and PES-NWI), bearing in
mind the sociodemographic and occupational characteris-
tics of the sample. Differential analyses will be conducted
to generate specific profiles, using general linear model
analysis techniques. The individual and contextual factors
reported by the respondents will be modeled, taking into
account personal and occupational characteristics and the
hospital ward using a multi-level analysis.
Randomization
Wards will be randomly allocated to the intervention or
control arm using software, in blocks 1:1 with stratifica-
tion by setting (medical or surgical) and hospital (to en-
sure homogeneity of both groups).
Blinding
Hypothesis and variables will be blind to prevent any se-
lection bias that might arise in the nurses participating
in the data collection process. All research assistants will
be blinded to group allocation. Success of blinding will
be assessed at study end using the James Blinding Index.
Although FIREs and intervention wards will not be
blinded, control wards will be blinded. Patients will be
unaware of the intervention. IBM and JDP analyze the
data, all will be blinded to group allocation.
Discussion
Clinical implementation is a complex, multifaceted
phenomenon [26] which requires a deep understanding
of decision-making, knowledge mobilization, and sense-
making in routine clinical practice [49]. Likewise, the in-
clusion of strategies that promote fidelity [50] to recom-
mendations through multicomponent and multimodal
interventions [51, 52] must be encouraged. The identifi-
cation of barriers and constraints at the level of institu-
tions and individuals involved should be the first step
[53]. The use of a transfer model could counterbalance
one of the greatest challenges for organizations, the
evaluation of the impact of the implementation of re-
search evidence in the professional context through
quality indicators associated with prevention and control
of infections [54, 55]. Although life-threatening adverse
events such as CRBSIs have a low incidence in our setting,
the volume of PVC use amplifies its importance in terms
of morbidity, mortality, and patient safety. An important
limitation may be the low potential to reduce PVC-BSIs
rates of through multimodal intervention [32, 56].
This protocol study will include the facilitation elem-
ent based on the PARIHS framework, a key aspect with
the potential to make substantial contributions to know-
ledge in this area [26, 41].
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